GlassScriptPhysician profile
Anna S Yi
NPI 1043524283
$1,470.99
in general payments reported to CMS, 2019-2025
17 companies · $456 in 2025
The $456 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $171 · 2021: $118 · 2022: $160 · 2023: $25.74 · 2024: $310 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $790.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $284.06 | 2022-2025 | Xiidra, Infuse, Vyzulta |
| Alcon Vision LLC | $240.19 | 2022-2025 | Dailies Total1, Total30, Precision7 |
| Novartis Pharmaceuticals Corporation | $195.50 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $113.14 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $92.77 | 2024 | |
| Oyster Point Pharma, INC. | $82.71 | 2022-2025 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $78.10 | 2024-2025 | Xdemvy |
| Allergan, INC. | $76.23 | 2019-2022 | |
| Coopervision INC. | $56.46 | 2019 | |
| Sun Pharmaceutical Industries INC. | $44.37 | 2024 | |
| Harrow Eye, LLC | $38.23 | 2025 | Vevye |
| Eyevance Pharmaceuticals LLC | $37.95 | 2019-2020 | |
| Shire North American Group INC | $31.49 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $27.34 | 2019-2021 | |
| Dompe US, INC. | $27.31 | 2024 | Oxervate |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $25.74 | 2023 | Vuity, Alphagan P, Lumigan |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Yi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.